Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
GEMCITABINE ELAIDATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GEMCITABINE ELAIDATE
×
Maximum Phase:
2
First Approval:
None
UNII:
231C73W7LG
Molecule Type:
Small molecule
Molecular Formula:
C27H43F2N3O5
Molecular Weight:
527.65
AlogP:
5.3
PSA:
116.67
HBD:
2.0
HBA:
#RotB:
18.0
Source:
ONO-8539
(2)
Small molecule
Prostanoid EP1 receptor antagonist
Unknown
Investigational
Unknown
ONO-8539
×
Maximum Phase:
2
First Approval:
None
UNII:
94W010PZ1Z
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S2
Molecular Weight:
500.64
AlogP:
5.07
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ADAFOSBUVIR
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
ADAFOSBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
S83770Y75R
Molecule Type:
Small molecule
Molecular Formula:
C22H29FN3O10P
Molecular Weight:
545.46
AlogP:
0.98
PSA:
178.41
HBD:
4.0
HBA:
#RotB:
10.0
Source:
NAZARTINIB
(2)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
NAZARTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
KE7K32EME8
Molecule Type:
Small molecule
Molecular Formula:
C26H31ClN6O2
Molecular Weight:
495.03
AlogP:
4.32
PSA:
83.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TALVIRALINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TALVIRALINE
×
Maximum Phase:
2
First Approval:
None
UNII:
XZ4KT6MO4X
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2O3S2
Molecular Weight:
340.47
AlogP:
3.53
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BI-2536
(2)
Small molecule
Serine/threonine-protein kinase PLK1 inhibitor
Unknown
Investigational
Unknown
BI-2536
×
Maximum Phase:
2
First Approval:
None
UNII:
4LJG22T9C6
Molecule Type:
Small molecule
Molecular Formula:
C28H39N7O3
Molecular Weight:
521.67
AlogP:
3.56
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SHP-627
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SHP-627
×
Maximum Phase:
2
First Approval:
None
UNII:
C6V7ZU2NPR
Molecule Type:
Small molecule
Molecular Formula:
C20H17NO5
Molecular Weight:
351.36
AlogP:
3.06
PSA:
84.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
IP-2018
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IP-2018
×
Maximum Phase:
2
First Approval:
None
UNII:
60XT58V8NZ
Molecule Type:
Small molecule
Molecular Formula:
C16H17NO3
Molecular Weight:
271.32
AlogP:
2.45
PSA:
51.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CMX-2043
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CMX-2043
×
Maximum Phase:
2
First Approval:
None
UNII:
83V80O4XY1
Molecule Type:
Small molecule
Molecular Formula:
C16H26N2O6S2
Molecular Weight:
406.53
AlogP:
1.64
PSA:
132.8
HBD:
4.0
HBA:
#RotB:
12.0
Source:
SOFINICLINE
(2)
Small molecule
Neuronal acetylcholine receptor; alpha4/beta2 agonist
Unknown
Investigational
Unknown
SOFINICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
SQC232V4YY
Molecule Type:
Small molecule
Molecular Formula:
C10H11Cl2N3
Molecular Weight:
244.12
AlogP:
1.8
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BRIVUDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BRIVUDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2M3055079H
Molecule Type:
Small molecule
Molecular Formula:
C11H13BrN2O5
Molecular Weight:
333.14
AlogP:
-0.46
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AZD9056
(2)
Small molecule
P2X purinoceptor 7 antagonist
Unknown
Investigational
Unknown
AZD9056
×
Maximum Phase:
2
First Approval:
None
UNII:
F13K378W4L
Molecule Type:
Small molecule
Molecular Formula:
C24H35ClN2O2
Molecular Weight:
419.01
AlogP:
4.19
PSA:
61.36
HBD:
3.0
HBA:
#RotB:
10.0
Source:
TELAGLENASTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TELAGLENASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
U6CL98GLP4
Molecule Type:
Small molecule
Molecular Formula:
C26H24F3N7O3S
Molecular Weight:
571.59
AlogP:
4.55
PSA:
131.88
HBD:
2.0
HBA:
#RotB:
12.0
Source:
TIPELUKAST
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TIPELUKAST
×
Maximum Phase:
2
First Approval:
None
UNII:
08379P260O
Molecule Type:
Small molecule
Molecular Formula:
C29H38O7S
Molecular Weight:
530.68
AlogP:
6.51
PSA:
110.13
HBD:
2.0
HBA:
#RotB:
17.0
Source:
AZD4818
(2)
Small molecule
C-C chemokine receptor type 1 antagonist
Unknown
Investigational
Unknown
AZD4818
×
Maximum Phase:
2
First Approval:
None
UNII:
S5UP6P540K
Molecule Type:
Small molecule
Molecular Formula:
C24H32ClN3O4
Molecular Weight:
461.99
AlogP:
3.39
PSA:
94.06
HBD:
4.0
HBA:
#RotB:
9.0
Source:
HYDROXYFLUTAMIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
HYDROXYFLUTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
31D90UKP5Y
Molecule Type:
Small molecule
Molecular Formula:
C11H11F3N2O4
Molecular Weight:
292.21
AlogP:
2.32
PSA:
92.47
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MB-07803
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MB-07803
×
Maximum Phase:
2
First Approval:
None
UNII:
GG81XF45C2
Molecule Type:
Small molecule
Molecular Formula:
C24H37N4O7PS
Molecular Weight:
556.62
AlogP:
3.9
PSA:
162.85
HBD:
3.0
HBA:
#RotB:
11.0
Source:
NAVAFENTEROL
(2)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Investigational
Unknown
NAVAFENTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
U29GY32XJ4
Molecule Type:
Small molecule
Molecular Formula:
C38H42N6O6S2
Molecular Weight:
742.92
AlogP:
5.04
PSA:
165.83
HBD:
5.0
HBA:
#RotB:
14.0
Source:
CB-103
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CB-103
×
Maximum Phase:
2
First Approval:
None
UNII:
Q5BB91JL0V
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
3.75
PSA:
48.14
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ADL-5747
(2)
Small molecule
Delta opioid receptor agonist
Unknown
Investigational
Unknown
ADL-5747
×
Maximum Phase:
2
First Approval:
None
UNII:
24QBI4WA54
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClN2O3
Molecular Weight:
428.96
AlogP:
3.82
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HISTIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
HISTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4QD397987E
Molecule Type:
Small molecule
Molecular Formula:
C6H9N3O2
Molecular Weight:
155.16
AlogP:
-0.64
PSA:
92.0
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PEMRAMETOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PEMRAMETOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
VXT8SZ6875
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
1.05
PSA:
110.69
HBD:
3.0
HBA:
#RotB:
7.0
Source:
6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRC-6211
(2)
Small molecule
Vanilloid receptor antagonist
Unknown
Investigational
Unknown
GRC-6211
×
Maximum Phase:
2
First Approval:
None
UNII:
4S841S9BO9
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMPLITAPIDE
(2)
Small molecule
Microsomal triglyceride transfer protein inhibitor
Unknown
Investigational
Unknown
IMPLITAPIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q70OH404HR
Molecule Type:
Small molecule
Molecular Formula:
C35H37N3O2
Molecular Weight:
531.7
AlogP:
6.98
PSA:
67.15
HBD:
2.0
HBA:
#RotB:
8.0
Source:
MISONIDAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MISONIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8FE7LTN8XE
Molecule Type:
Small molecule
Molecular Formula:
C7H11N3O4
Molecular Weight:
201.18
AlogP:
-0.2
PSA:
90.42
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ETAZOLATE
(2)
Small molecule
GABA receptor beta-3 subunit positive allosteric modulator
Unknown
Investigational
Unknown
ETAZOLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
I89Y79062L
Molecule Type:
Small molecule
Molecular Formula:
C14H19N5O2
Molecular Weight:
289.34
AlogP:
2.44
PSA:
81.4
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OSUNPROTAFIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
OSUNPROTAFIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABC-294640
(2)
Small molecule
Sphingosine kinase 2 inhibitor
Unknown
Investigational
Unknown
ABC-294640
×
Maximum Phase:
2
First Approval:
None
UNII:
DRG21OQ517
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClN2O
Molecular Weight:
380.92
AlogP:
4.89
PSA:
41.99
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GRANOTAPIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GRANOTAPIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
PSZ2YGB0DK
Molecule Type:
Small molecule
Molecular Formula:
C39H37F3N2O8
Molecular Weight:
718.73
AlogP:
6.48
PSA:
128.31
HBD:
1.0
HBA:
#RotB:
13.0
Source:
ABEDITEROL
(2)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Investigational
Unknown
ABEDITEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
QXA167CM6F
Molecule Type:
Small molecule
Molecular Formula:
C25H30F2N2O4
Molecular Weight:
460.52
AlogP:
4.23
PSA:
94.58
HBD:
4.0
HBA:
#RotB:
13.0
Source:
GSK-2636771
(2)
Small molecule
PI3-kinase p110-beta subunit inhibitor
Unknown
Investigational
Unknown
GSK-2636771
×
Maximum Phase:
2
First Approval:
None
UNII:
DW94IAT0LS
Molecule Type:
Small molecule
Molecular Formula:
C22H22F3N3O3
Molecular Weight:
433.43
AlogP:
4.26
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NAVARIXIN
(2)
Small molecule
Interleukin-8 receptor A antagonist
Unknown
Investigational
Unknown
NAVARIXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
7V3BY6G538
Molecule Type:
Small molecule
Molecular Formula:
C21H23N3O5
Molecular Weight:
397.43
AlogP:
2.9
PSA:
111.88
HBD:
3.0
HBA:
#RotB:
7.0
Source:
LERIGLITAZONE
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
Unknown
Investigational
Unknown
LERIGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
K824X25AYA
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O4S
Molecular Weight:
372.45
AlogP:
2.65
PSA:
88.52
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AVN-944
(2)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Unknown
Investigational
Unknown
AVN-944
×
Maximum Phase:
2
First Approval:
None
UNII:
I3NPL1V48Q
Molecule Type:
Small molecule
Molecular Formula:
C25H27N5O5
Molecular Weight:
477.52
AlogP:
5.47
PSA:
138.51
HBD:
3.0
HBA:
#RotB:
9.0
Source:
NV-5138
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NV-5138
×
Maximum Phase:
2
First Approval:
None
UNII:
06CA9QMG6Z
Molecule Type:
Small molecule
Molecular Formula:
C7H13F2NO2
Molecular Weight:
181.18
AlogP:
1.08
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
124
125
126
127
128
129
130
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA